Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04836091 · ClinicalTrials.gov registry record · NA

Acceptability, Feasibility and Preliminary Impact of OurPlan, an mHealth HIV Prevention Intervention for Male Couples

A NA study, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT04836091: Completed NA study, sponsored by Florida International University.

NCT04836091 is a NA study that has completed, run by Florida International University. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04836091, a NA study, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

The study will evaluate the use and preliminary impact of an mHealth app for improving sexual health outcome measures among male couples by assessing whether exposure and use of the app results in improvements in participants and couples' self-reported sexual health and prevention behaviors, beliefs, and attitudes. The study will enroll both men of the couple into a randomized controlled trial. Participants/couples randomized to the intervention will have access to the app for two months while those assigned to the waitlist group will receive and have access to the app for one month. Participants will complete surveys at baseline and at month 2.

Primary Outcome

Men will be asked if they created a detailed risk-reduction plan containing evidence-based strategies of routine HIV/STI testing, consistent condom use, PrEP, and ART

Interventions

  • BEHAVIORAL Intervention
  • BEHAVIORAL Waitlist

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2021-03-16
Est. Completion 2021-07-31
Phase NA
Florida International University

89 total trials

What the finished NCT04836091 record still lists

NCT04836091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Intervention is the first listed.

NCT04836091 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04836091 about?

NCT04836091 is a clinical study titled "Acceptability, Feasibility and Preliminary Impact of OurPlan, an mHealth HIV Prevention Intervention for Male Couples". The study will evaluate the use and preliminary impact of an mHealth app for improving sexual health outcome measures among male couples by assessing whether exposure and use of the app results in improvements in participants and couples' self-reported sexual health and prevention behaviors, beliefs...

What is the current status of trial NCT04836091?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2021-03-16. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT04836091?

The interventions under investigation include: Intervention (BEHAVIORAL), Waitlist (BEHAVIORAL).

Who is sponsoring clinical trial NCT04836091?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04836091's enrollment target sits among peer trials

84 983rd of 2000 higher than 1,011 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04836091, the US trial registry maintained by the National Library of Medicine. NCT04836091 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.